Status:
UNKNOWN
Effect of Moxifloxacin Versus Gatifloxacin on Corneal Epithelium Following Pterygium Excision
Lead Sponsor:
Meir Medical Center
Conditions:
Primary Pterygium
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether there is a difference in corneal epithelial healing rate and/or toxicity following pterygium excision, between eyes treated post-operatively by moxifl...
Eligibility Criteria
Inclusion
- diagnosis of primary pterygium with a clinical indication for surgery
- informed consent
Exclusion
- known allergic reaction to fluoroquinolones.
- secondary\\recurrent pterygium or clinical suspected conjunctival tumor.
- eye surgery in the last 6 months.
- eye disorders: severe dry eye syndrome, ocular surface diseases, glaucoma, recurrent corneal erosions, chronic corneal diseases, after chemical burn.
- low compliance.
- pregnancy
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2010
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00892918
Start Date
June 1 2009
End Date
June 1 2010
Last Update
May 5 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Meir Medical Center
Kfar Saba, Israel, 44281